SelectMDx improves prostate biopsy decision-making in urology practices

Go back to SelectMDx improves prostate biopsy decision-making in urology practices
(NASDAQ: MDXH) Delayed: 0.47 -0.04 (7.84%)
Previous Close $0.51    52 Week High
Open $0.52    52 Week Low
Day High $0.55    P/E N/A 
Day Low $0.47    EPS
Volume 804,895